Lung cancer in never-smokers exhibits distinct biological characteristics, often leading to late-stage diagnoses due to lack of screening. Targeted therapies, guided by molecular testing, offer ...

Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah, discusses the latest advancements in HR+/HER2– breast cancer research, as well as the ...

Thoracic medical oncologists and early drug development specialists at Memorial Sloan Kettering Cancer Center (MSK) continue to investigate new ways to improve outcomes for this patient population.

Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapies, cancer genomics, using AI to personalize cancer treatment, improving diagnosis of hard-to-treat ...

Chemotherapy is one of the most commonly used treatments for cancer, but it can cause side effects. Alternatives include surgery, targeted therapy, and laser therapy. More than 100 types of cancer ...

Bioengineering aims to improve targeted cancer therapies by enhancing drug delivery, boosting immune responses, and refining surgical techniques. The field is highly interdisciplinary, merging ...

This year, there was a surge of new lung cancer treatments, more options for patients with earlier-stage disease, and growing ...

Cancer diagnosis used to be a simple, binary call: either someone had the disease or they didn’t. And patients with the same broad class of cancer tend to receive the same class of therapy. It was a ...

Targeted protein degradation (TPD) therapy is a promising new class of targeted treatments. Based on a cell’s natural mechanism for eliminating diseased proteins, this therapy can combat hard-to-treat ...